Louisiana State University

LSU Digital Commons
Faculty Publications

Department of Entomology

1-1-1999

Acute clinical disease in cats following infection with a
pathogenic strain of Bartonella henselae (LSU16)
Kathy L. O'Reilly
School of Veterinary Medicine

Rudy W. Bauer
School of Veterinary Medicine

Rebecca L. Freeland
School of Veterinary Medicine

Lane D. Foil
Louisiana State University

Keith J. Hughes
School of Veterinary Medicine

See next page for additional authors

Follow this and additional works at: https://digitalcommons.lsu.edu/entomology_pubs

Recommended Citation
O'Reilly, K., Bauer, R., Freeland, R., Foil, L., Hughes, K., Rohde, K., Roy, A., Stout, R., & Triche, P. (1999). Acute
clinical disease in cats following infection with a pathogenic strain of Bartonella henselae (LSU16).
Infection and Immunity, 67 (6), 3066-3072. https://doi.org/10.1128/iai.67.6.3066-3072.1999

This Article is brought to you for free and open access by the Department of Entomology at LSU Digital Commons.
It has been accepted for inclusion in Faculty Publications by an authorized administrator of LSU Digital Commons.
For more information, please contact ir@lsu.edu.

Authors
Kathy L. O'Reilly, Rudy W. Bauer, Rebecca L. Freeland, Lane D. Foil, Keith J. Hughes, Kristen R. Rohde, Alma
F. Roy, Rhett W. Stout, and Patricia C. Triche

This article is available at LSU Digital Commons: https://digitalcommons.lsu.edu/entomology_pubs/249

INFECTION AND IMMUNITY, June 1999, p. 3066–3072
0019-9567/99/$04.0010
Copyright © 1999, American Society for Microbiology. All Rights Reserved.

Vol. 67, No. 6

Acute Clinical Disease in Cats following Infection with a
Pathogenic Strain of Bartonella henselae (LSU16)
KATHY L. O’REILLY,1* RUDY W. BAUER,2 REBECCA L. FREELAND,1 LANE D. FOIL,3
KEITH J. HUGHES,1† KRISTEN R. ROHDE,1 ALMA F. ROY,1 RHETT W. STOUT,4
1
AND PATRICIA C. TRICHE
Department of Veterinary Microbiology and Parasitology,1 Department of Veterinary Pathology,2 and Division of
Laboratory Animal Medicine,4 School of Veterinary Medicine, and Department of Entomology,3 Louisiana State
University, Baton Rouge, Louisiana 70803

Bartonella henselae is the causative agent of human cat scratch disease as well as several serious sequelae of
infections, including bacillary angiomatosis and bacillary peliosis. Conflicting reports describe the pathogenesis of B. henselae in the cat. In this study, we characterized a strain of B. henselae termed LSU16. This strain
was isolated on rabbit blood agar from a naturally infected 10-month-old female cat during a recurrent episode
of bacteremia. The bacterial species was confirmed by PCR-restriction fragment length polymorphism analysis.
Nine cats were infected intradermally with 5 3 107 CFU of LSU16, and clinical signs, antibody responses, and
bacteremia were monitored. All nine cats developed raised, erythematous areas at the site of inoculation within
72 h postinoculation; the swelling peaked at 14 days postinfection and was not palpable by 28 days postinfection. Fever developed in all nine cats between 6 and 16 days postinfection and lasted for 1 to 8 days. Between
6 and 16 days postinfection, all nine cats experienced lethargy which persisted 5 to 18 days. Seven of nine cats
were bacteremic by day 7, and all nine cats had become bacteremic by 14 days postinfection. Bacteremia peaked
at 14 to 28 days postinfection in all cats. In six of the nine infected cats, bacterial numbers reached nondetectable levels during the 7th week postinfection; however, a single animal maintained bacteremia to 18 weeks
postinfection. All nine cats developed strong antibody responses to B. henselae, as determined by Western blot
analysis and enzyme-linked immunosorbent assay. Subsequently, three naive cats were injected intradermally
with blood from cats infected with LSU16 from a pure culture, and five naive cats were injected with feces from
fleas which had been feeding on cats infected with a pure culture of LSU16. These cats developed signs similar
to those described in the previous experiment and were euthanized at 5 weeks postinfection. We conclude that
B. henselae LSU16 is a virulent strain of B. henselae in cats and propose that the virulence of B. henselae in cats
is strain dependent.
henselae have recurrent periods of bacteremia, and during
these periods of bacteremia they do not show clinical signs of
disease (15). There are conflicting reports with regard to clinical signs in experimentally infected cats. Abbott et al. (1) and
Regnery et al. (17) reported no clinical signs in experimentally
infected cats. Guptill et al. (5) reported mild clinical signs
which included mild fever as well as histopathologic lesions in
some cats to 8 weeks postinfection. Kordick and Breitschwerdt
(8) reported fever in six of eight experimentally infected cats
and signs of abnormal central nervous system (CNS) disease in
two cats. These findings are difficult to compare because of
differences in the strain used to infect the cats, the route of
infection, and the size of the inoculum.
Studies of the pathogenesis of B. henselae require a thorough
characterization of the strain that is used. In this study, we
characterized a strain of B. henselae, termed LSU16, which is
pathogenic in experimentally infected cats and which produces
a reproducible disease. We describe pathogenic events following intradermal (i.d.) inoculation of cats, including bacteremia
and clinical signs, and discuss the usefulness of this strain for
future studies involving characterization of B. henselae infection of cats.

Bartonella henselae, a gram-negative, oxidase-negative, nonflagellated, fastidious aerobic bacterium, is the causative agent
of a wide range of clinical disease syndromes in human patients, including cat scratch disease (CSD). The typical CSD,
which is seen in the majority of immunocompetent patients, is
characterized by lymphadenopathy in the nodes draining the
site of a cat scratch. Local lesions exhibiting redness, swelling,
and/or a pustule at the site of the scratch may also develop but
are not consistently seen. The involved lymph node usually
regresses over a period of weeks to months. Patients may also
experience fever, malaise, anorexia, and/or headache 7 to 10
days following exposure and painful lymphadenopathy in moderate or severe CSD. In approximately 10% of cases, the
lymphadenopathy associated with CSD may proceed to suppuration. Serious sequelae, including ocular disease, encephalopathy, osteolytic lesions, and life-threatening bacillary angiomatous and bacillary peliosis, occur in a small percentage of
immunocompetent individuals (2, 11, 19).
B. henselae is a zoonotic agent, and cats are the natural
carrier (6, 22); however, the pathogenesis of B. henselae in the
cat is not clearly understood. Cats naturally infected with B.
* Corresponding author. Mailing address: Department of Veterinary Microbiology and Parasitology, School of Veterinary Medicine,
Louisiana State University, Baton Rouge, LA 70803. Phone: (225)
346-3307. Fax: (225) 346-5715. E-mail: oreilly@mail.vetmed.lsu.edu.
† Present address: Department of Biological Sciences, Delta State
University, Cleveland, Miss.

MATERIALS AND METHODS
Cats. Thirty-two 7- to 15-month-old cats, purchased either as conditioned
pound source cats from the Louisiana State University Division of Laboratory
Animal Medicine or as specific-pathogen-free (SPF) cats from Harlan SpragueDawley (Madison, Wis.), were used in these experiments. All of the cats were
culture negative for B. henselae and antibody negative for B. henselae by Western
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TABLE 1. Adverse clinical signs among cats inoculated with a pure culture of B. henselae LSU16
No. of cats exhibiting:
Cat no.

37
39
40
50
54
58
182
184
223

a

Source

LSU
LSU
LSU
LSU
LSU
LSU
HSD
HSD
HSD

Mean 6 SD

b

Inoculum (CFU)

Age (mo)

Fever

c

Depression

Starting dayd

Duration (days)

Starting dayd

Duration (days)

7

5 3 10
5 3 107
5 3 107
5 3 107
5 3 107
5 3 107
5 3 107
5 3 107
5 3 107

14
15
14
15
15
14
7
7
7

10
11
10
16
6
10
13
16
14

4
5
3
1
8
3
5
2
5

10
13
10
13
15
10
11
11
11

8
9
8
7
5
8
8
11
12

5 3 107

12

12 6 3

462

12 6 2

862

a

blot analysis. The cats were housed individually and supplied with water and
laboratory maintenance diet ad libidum. All cats were wormed and were vaccinated against the common infectious diseases of cats. The sources of individual
cats are indicated in Tables 1 through 3.
Isolation and propagation of B. henselae LSU16. Cat no. 16, a female domestic
short-haired cat that was antibody positive for Bartonella species, was purchased
from the East Baton Rouge Parish Humane Society at approximately 16 weeks
of age. After being conditioned, cat 16 was treated with Advantage (Bayer Corp.,
Shawnee Mission, Kans.) according to the manufacturer’s instructions to kill
ectoparasites and with Ivermectin (Merck & Co., Inc., Rahway, N.J.) to kill ear
mites and subsequently housed in a single-animal cage. Blood was collected
weekly from cat 16, and serial dilutions of the blood were cultured for the
presence of Bartonella sp. on rabbit blood agar plates. Cat 16 was negative by
culture for 20 weeks. During the 21st week, 1,000 CFU of an organism consistent
with B. henselae was cultured per ml of cat 16 blood. The isolate, termed LSU16,
had a colony morphology consistent with that of B. henselae and was confirmed
to be B. henselae by PCR-restriction fragment length polymorphism analysis as
previously reported (8). The initial isolate of LSU16 was expanded twice on
chocolate agar under an atmosphere of 5% CO2 at 37°C. Bacterial lawns were
harvested after 5 to 8 days of culture, suspended in heart infusion broth with 25%
glycerol, and stored as aliquots at 270°C. Before inoculation into cats, these
aliquots of B. henselae were thawed and the culture was centrifuged to remove
the freezing medium. The bacterial pellet was then suspended in saline to the
appropriate concentration prior to inoculation, and the actual number of CFU
per milliliter and the purity of the culture were confirmed by culturing serial
dilutions on chocolate agar under an atmosphere of 5% CO2 at 37°C for 7 days.
All animal inoculations were conducted with a second-passage preparation.
Bacteremia in experimentally infected cats was determined by culturing serial
dilutions of whole blood on chocolate agar under an atmosphere of 5% CO2 at
37°C for 7 days.
Infection of cats. Nine cats were each given 5 3 107 CFU of LSU16 bacterial
culture. Subsequently, three cats were given 1 ml of blood from one of three cats
infected with a pure culture of LSU16 14 days previously. Five cats were injected
with 45 mg of feces from fleas that had fed on LSU16-infected cats for 4 days as

previously described (4). All cats were injected i.d. with 1.0 ml of the respective
inocula, divided among six sites on the skin of the lateral trunk. The sites of
inoculation were marked with a water-indelible marker and monitored daily.
Collection of samples from cats. Prior to sample collection, cats were anesthetized with Telazol (Fort Dodge, Ames, Iowa) at the dosage recommended by
the manufacturer. All cats were bled weekly by jugular puncture, using a 10-ml
syringe and a 21-gauge needle, and the blood was distributed among 1.5-ml
pediatric lysis-centrifugation isolator tubes (Wampole Laboratories, Cranbury,
N.J.) for culture and among an EDTA tube and serum Vacutainer tubes (Becton-Dickinson, Franklin Lakes, N.J.) for complete blood counts and serological
testing, respectively. Serum was collected by centrifugation of clotted blood at
800 3 g and was frozen in aliquots at 220°C. Spinal fluid samples were aseptically collected by cerebellomedullary cisternal puncture from three anesthetized
cats which had shown signs of possible CNS involvement. Cytologic preparations
and creatine phosphokinase levels were examined, and the cerebrospinal fluid
was cultured for the presence of B. henselae. Urine, spinal fluid, and tissues were
collected from cats at necropsy for culture of B. henselae.
Clinical signs. All cats were monitored daily for clinical signs of disease. To
enumerate clinical disease, each of the following signs was assigned one point:
swelling and/or redness at the site of inoculation, temperature of 39.5 to 40.5°C,
temperature over 40.5°C, palpable lymphadenopathy (popliteal, prescapular,
and/or submandibular lymph nodes), diarrhea, vomiting, anorexia, aggression,
and lethargy. Cats received one point each week for each of the clinical signs
which were observed within 1 week.
Analysis of antibody responses of cats to B. henselae LSU16. The immunoglobulin G (IgG) and IgM responses to B. henselae LSU16 were monitored by
enzyme-linked immunosorbent assay (ELISA) as previously described (4).

RESULTS
Bacteremia in cats infected with LSU16. Nine animals were
each given 5 3 107 CFU of LSU16, three animals were each
given blood containing an average of 6.2 3 105 CFU/ml, and

TABLE 2. Adverse clinical signs among cats inoculated with blood from B. henselae LSU16-infected cats
No. of cats exhibiting:
Cat no.

7
156
190
Mean 6 SD
a

a

Source

LSU
HSD
HSD

b

c

Inoculum, CFU

Age (mo)

5

Blood (223), 3.6 3 10
Blood (182), 5.1 3 105
Blood (184), 1.0 3 106

14
14
7

6.2 3 105

11.7

Fever

d

Depression

Starting daye

Duration (days)

Starting daye

Duration (days)

21
18
18

2
3
4

22
18
21

11
7
11

19 6 2

361

20 6 2

10 6 2

Cats were purchased from either the Division of Laboratory Animal Medicine at Louisiana State University (LSU) or Harlan Sprague-Dawley (HSD).
The cat number in parentheses indicates the source of the blood and refers to a cat in Table 1.
Age at the time of infection.
d
Rectal temperature of .103.0°F (39.4°C).
e
Day postinoculation that sign was first evident.
b
c
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Cats were purchased from either the Division of Laboratory Animal Medicine at Louisiana State University (LSU) or Harlan Sprague-Dawley (HSD).
b
Age at the time of infection.
c
Rectal temperature of .103.0°F (39.4°C).
d
Day postinoculation that sign was first evident.
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TABLE 3. Adverse clinical signs in cats inoculated with feces from fleas feeding on cats infected with pure cultures of B. henselae LSU16
No. of cats exhibiting:
Cat no.

Source

353
359
357
350
225

a

b

Age (mo)

Fever

Depression

Starting dayd

Duration (days)

Starting dayd

Duration (days)

5
5
5
5
7

15
16
12
18
12

4
3
6
1
6

15
16
14
15
7

5
7
8
5
14

561

15 6 3

462

13 6 4

864

HSD
HSD
HSD
HSD
HSD

Mean 6 SD

c

a

five animals were each given 45 mg of feces from fleas feeding
on cats infected with LSU16. In addition, 15 cats not exposed
to B. henselae were also monitored. All 17 cats infected with B.
henselae LSU16 developed high levels of bacteremia, regardless of the inoculum used. All of the cats exposed to a pure
culture of LSU16 were bacteremic by week 2, but seven of nine
had developed bacteremia by 7 days (Fig. 1). Peak bacteremia
occurred between week 2 (seven of nine cats) and week 4 (one
of nine animals). The number of CFU of B. henselae in the
blood inocula was lower than that in the pure-culture inocula
(Table 2) and may have resulted in a slower onset of bacteremia in those cats given blood. The number of CFU in flea feces
could not be accurately measured due to the presence of other
organisms in the inoculum and was also presumed to be
smaller than that of cats receiving pure-culture inocula. Only
six of eight cats receiving blood or flea feces were bacteremic
by week 2; however, all of the cats in both groups were bacteremic by week 3. Peak bacteremia occurred in most cats by
week 2 (6 of 14) or week 3 (7 of 17). The number of bacteria
began to wane after 4 weeks, and five of nine cats were negative by 8 weeks postinfection. Of the cats infected with pureculture inoculum, only one (no. 58) was culture positive at 12
weeks, and that cat remained positive until 18 weeks postinfection and then remained negative until week 22, when the
experiment was terminated. The eight cats infected with either
blood or flea feces showed a similar pattern, with a slightly
slower onset of bacteremia (Fig. 1); however, these cats were

euthanized 8 weeks postinfection, while all eight cats were still
bacteremic.
Clinical disease in cats infected with LSU16. Table 4 lists
the clinical signs that were seen in the cats, and the mean
clinical scores for the animals are presented in Fig. 2. Every cat
exposed to B. henselae developed fever and became somewhat
sluggish and lethargic between 6 and 21 days postinoculation.
In addition, 15 of the 17 cats developed strong, gross inflammatory lesions at the sites of inoculation, and 3 of the cats
developed pustules. In most cats, these lesions started to develop by 72 hours postinoculation, became red and hard by 10
days postinoculation, and then gradually regressed over the
next 14 to 18 days. All 17 cats were observed to have decreased
appetites, but 8 of the 17 cats required force feeding and/or
subcutaneous fluid replacement for up to 10 days. One infected
animal was observed to have vomited once, and one infected
cat had intermittent soft stools during the period of anorexia;
however, since intermittent soft stools were seen in 2 of the 15
control cats (data not shown), this was probably not related to
the infection. There were no significant differences in erythrocytes, lymphocytes, monocytes, or neutrophils, either in percentage or absolute number, between the infected and noninfected groups (data not shown).
Palpable lymph node enlargements were observed in five of
six pure-culture-infected cats and in all of the cats that received
the blood or flea feces inoculum. The enlargement of the
lymph nodes was first observed at week 2 postinfection and

TABLE 4. Adverse clinical signs in cats inoculated with B. henselae LSU16
Sign
b

Fever
Lethargy
Swelling and/or redness at site of inoculation
Pustule at site of inoculation
Anorexia
Anorexia requiring force feeding and/or fluids
Vomiting
Muscle pain or stiffness
Abnormal or aggressive behavior
Lymphadenopathy
a
b
c

No. of cats exhibiting sign/total no. (%) inoculated witha:
Uninfected (controls)

Pure culture of LSU16

Infected blood

Infected flea feces

0/15 (0)
0/15 (0)
0/15 (0)
0/15 (0)
0/15 (0)
0/15 (0)
0/15 (0)
0/15 (0)
0/15 (0)
7/15 (47)

9/9 (100)
9/9 (100)
9/9 (100)
3/9 (33)
9/9 (100)
3/6 (50)
1/9 (11)
8/9 (89)
5/9 (56)
5/6c (83)

3/3 (100)
3/3 (100)
3/3 (100)
0/3 (0)
3/3 (100)
0/3 (0)
0/3 (0)
2/3 (67)
0/3 (0)
3/3 (100)

5/5 (100)
5/5 (100)
4/5 (80)
0/3 (0)
5/5 (100)
5/5 (100)
0/5 (0)
3/5 (60)
0/5 (0)
5/5 (100)

Number of cats that showed the indicated sign at any time in the study.
Rectal temperature of .103.0°F (39.4°C).
Three cats receiving pure-culture inocula were not monitored for lymphadenopathy during the first 4 weeks postinfection and were excluded.
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Cats were purchased from Harlan Sprague-Dawley (HSD).
b
Age at the time of infection.
c
Rectal temperature of .103.0°F (39.4°C).
d
Day postinoculation that sign was first evident.

FIG. 1. Mean levels of bacteremia in B. henselae-infected cats. Shown are
mean CFU per milliliter values determined for blood of cats infected with a pure
culture of LSU16 (F) (n 5 9), blood from an LSU16-infected cat (ƒ) (n 5 3),
or feces from fleas feeding on a B. henselae LSU16-infected cat (■) (n 5 5).
Blood from cats infected with feces from fleas feeding on a B. henselae-infected
cat was not cultured in weeks 7 and 8. No organisms were cultured from the
blood of noninfected cats at any time during the course of this study.

continued for 2 to 4 weeks postinfection. These cats did not
show any significant sensitivity in the area of nodal enlargement. We observed sporatic enlargement of lymph nodes in 7
of the 15 noninfected cats.
Several cats (13 of the 17) showed a variety of other signs,
including muscle tenderness or pain, particularly along the
spine. Mild signs, consistent with CNS involvement, were seen
in 3 of the 17 cats. These included unusual sensitivities to
noise, light, and touch which resulted in an exaggerated startle
response or a vacant staring and reduced responsiveness to
external stimuli. These changes usually were observed 7 to 10
days postinfection and continued to up to 3 weeks postinfection. In addition, two cats showed abrupt behavior changes,
becoming aggressive and difficult to handle, in contrast to their
docile preinfection behavior. These two cats reverted to their
normal, nonaggressive behavior within 3 weeks.
Cerebrospinal fluid from three cats was tested during the
period of bacteremia and fever because the clinical signs suggested possible CNS involvement. B. henselae was not cultured
from the single spinal fluid that did not have blood contamination. The organism was cultured from two cats, but both
samples were contaminated with blood, and in both cases the
number of CFU per milliliter of spinal fluid was less than 0.5%
of the CFU per milliliter value of the matched blood sample
(data not shown). Further, creatine phosphokinase in the cerebrospinal fluid samples was within reference ranges (data not
shown).
B. henselae was not cultured from urine or spinal fluid but
was cultured from all tissues (lymph nodes, heart, lung, spleen,
liver, kidney, pancreas, thymus, testes or ovary, bone marrow,
and brain) collected from the euthanized cats. Although all
eight cats had one or more lymph nodes which appeared to be
enlarged, the number of organisms isolated from the tissue
samples was not significantly different from that in the blood,
and blood contamination of the tissues could not be ruled out
(data not shown).
Antibody responses to infection with LSU16. Antibody responses to infection with LSU16 were monitored by enzymelinked immunosorbent assay. As shown in Fig. 3, all of the cats
exposed to B. henselae LSU16 had high levels of IgG by 4
weeks postinfection, and these levels were maintained for the
duration of the study. We also examined the IgM response to
LSU16 and observed measurable levels of this immunoglobulin by week 3 postexposure. The IgM response began to wane
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FIG. 2. Mean clinical scores 6 standard deviations for 17 cats exposed to
strain LSU16 of B. henselae (F) and 15 noninfected cats (E). The clinical scores
of the two groups for weeks 2 and 3 were significantly different (P , 0.05).

by week 6; however, compared to the preinfection levels, IgM
levels remained elevated in the exposed cats for the duration of
the study.
DISCUSSION
The LSU16 strain of B. henselae caused a reproducible,
clinically characteristic disease in cats. We observed fever, anorexia, and lethargy in all 17 cats; redness and swelling at the
site of exposure in 16 of the 17 cats infected with a pure-culture
or blood inoculum; and myalgia, behavioral and/or neurological changes, and lymphadenopathy in many others. These signs
are compatible with those reported for human patients with
moderate to severe CSD (19). In contrast to human CSD, we
did not observe tenderness in those cats that had lymphadenopathy. All cats in this study were inoculated in the left or
right thorax, but the accessable lymph nodes (submandibular,
prescapular, and popliteal) were not the nodes draining the
site of inoculation. One has to consider the possibility that if
the inoculations had been done in a more peripheral site, the
lymphadenopathy might have been more similar to that reported in human patients.
The biology of B. henselae and the relationship of this organism to its feline host are poorly understood. It was reported
that naturally infected cats have periods of recurrent bacteremia and do not show overt signs of clinical disease during these
periods of bacteremia (9, 14). In fact, cat no. 16, from which
the strain LSU16 was isolated, did not show clinical signs
during the period of recurrent bacteremia. Studies using experimentally infected cats have provided conflicting evidence
on the relationship of B. henselae infection to disease in the cat.
Abbott et al. (1) infected 21 cats, 2 to 18 months of age, as well
as 4 pregnant queens by different routes and with different
doses ranging from 8 3 102 to 3.2 3 107 CFU and did not
observe signs of clinical disease in any of the animals. Similarly,
Regnery et al. (17) infected a total of 31 cats with 1 3 103 to
2 3 107 CFU of B. henselae (Houston-1 isolate), subcutaneously and i.d., and did not observe clinical disease in any of the
animals. Guptill et al. (5) infected 12 cats intravenously with
doses ranging from 106 to 1010 CFU and observed fever and
mild anorexia in 4 of the 12 animals. Kordick and Breitschwerdt (8) infected 18 cats with blood or urine and observed
that 4 had low-level fevers (39 to 40.3°C) and 8 had signs of
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FIG. 3. Box-and-whisker plot representation of the antibody responses of the 17 B. henselae LSU16-infected cats (A and B) and the 15 noninfected cats (C and D)
at each time point. IgM (A and C) and IgG (B and D) indices for each cat were calculated by dividing the ELISA optical density (450 nm) determined at each week
by the preinfection optical density. The index range which includes the 25th to the 75th percentiles is indicated by the hatched boxes. The 10th and 90th percentiles
are indicated by the lower and upper bars, respectively. The mean index for each week is indicated by the center bar. The black dots represent the outliers.

lymphadenopathy by 16 days postinfection which regressed
within 12 days. In addition, two of their infected cats developed
signs of CNS involvement, characterized by abnormal behavior
and vacant staring. In all of the experimental infections of cats
reported to date, a measurable bacteremia occurred as early as
7 days postinoculation and was transient, reaching undetectable levels in most cats by 12 weeks. (1, 5, 8, 17). In addition,
large numbers of organisms were seen in most cats, sometimes
exceeding 106/ml of blood. The bacteremia observed in
LSU16-inoculated cats was consistent with that seen in these
other studies, both in timing and in magnitude. Antibody responses in cats infected with LSU16 were also similar to those
reported by others. We observed an initial increase in IgM
levels, which subsequently waned over the course of the study
but did not return to baseline, suggesting continued antigen
stimulation. In addition, the levels of IgG increased during
week 2, continued to rise through week 8, and were henceforth
maintained throughout the duration of the study. This finding
is in contrast to that for the noninfected cats, which showed no
detectable changes in levels of either IgM or IgG antibodies to
B. henselae LSU16.
The adverse clinical signs that we observed in our cats following infection with B. henselae LSU16 are consistent with the
timing and clinical signs observed by other researchers, i.e.,
fever, anorexia, lymphadenopathy, and abnormal behavior;
however, the signs observed with LSU16 appear to be less
variable and more severe than those previously reported. The
reasons for the observed differences can be hypothetically assessed. First, differences in the host could account for the

apparent increase in pathogenicity observed in our study. In
the studies reported to date, including the present study, SPF
cats were used; however, different vendors were used for each
study. Due to the care required to maintain SPF cats, differences in the genetic makeup of the cats might develop over
time and could account for the variability of pathogenesis of B.
henselae. However, like Guptill et al. (5), we used cats from
Harlan Sprague-Dawley, but in contrast to their study, we saw
evidence of consistent, reproducible disease in our cats. In
addition, we saw a nearly identical disease in outbred cats. Age
may be another factor. At 7 to 14 months, the cats used in our
study were significantly older than those used by Guptill et al.
(5). However, in another study we are currently conducting,
12-week-old kittens were inoculated with strain LSU16 and we
still observed fever, lethargy, and redness and swelling at the
site of inoculation (unpublished data).
Second, differences in the route of inoculation or the size of
the inoculum may affect the onset of clinical disease. The
inocula in the previously reported studies included blood and
urine (5) as well as pure cultures (1, 5, 8, 17), and the routes of
exposure used have included intravenous (1, 5, 7), i.d. (1, 17),
and intramuscular (8). Abbott et al. (1) compared routes of
inoculation and reported the most efficient infection via the i.d.
route. Based on that report, we chose an i.d. route, which
might account for our 100% infection rate. Significantly, we
used as inocula pure cultures, blood from infected cats, and
feces from fleas feeding on infected cats and were able to
demonstrate infection in all cases. Furthermore, we infected
cats with a pure culture of 5 3 107 CFU of LSU16, a signifi-
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cantly larger inoculum than was used by Abbott et al. for i.d.
inoculation. It is possible that many of the clinical signs we
observed were due to a response to endotoxin from the large
inoculum; however, we feel that this is unlikely because we
used 500-fold less inoculum than Guptill et al. (5), who did not
observe significant disease. The blood inoculum in this study
contained 50- to 140-fold fewer CFU of B. henselae than that
used in the pure-culture inocula. While the inoculation of
blood resulted in slightly slower kinetics, the observed disease
was indistinguishable from that seen in cats receiving pureculture inocula of LSU16. Further, we did not observe increased inflammation at the site of inoculation in cats receiving
flea feces compared to that seen in animals given pure-culture
or blood inocula, even though we were aware of the presence
of other organisms in the flea feces. Additionally, we injected
B. henselae-negative flea feces into naive cats (4) and did not
observe inflammation at the site of inoculation. Together,
these observations imply that the response to foreign antigens
other than B. henselae did not contribute significantly to the
inflammation observed in this study.
A third and highly likely explanation is that there are differences in the virulence of strains of B. henselae. Strain LSU16
was isolated from a naturally infected cat during a recurrent
bacteremic episode. This cat was not clinically ill at the time
that we isolated this strain. We kept the passage of the organism on artificial medium to a minimum; the organism used in
this study was from only a second-passage culture. Relman
(18) suggested that there are differences in virulence among
strains of B. henselae and that it is possible that particular
clones or strains are associated with specific clinical syndromes.
We are presently examining LSU16 to determine if we can
identify further differences between it and other strains of B.
henselae.
If the disease we have observed in association with LSU16 is
characteristic of many strains of B. henselae, this observation
could have important implications in both veterinary and human medicine. In veterinary medicine, fever and lethargy of
unknown etiology are commonly seen in cats. It is possible that
the initial infection of a kitten or cat with B. henselae will result
in fever and malaise of several days duration. Once the animal
then recovers from the primary infection, bacteremia could
then recur without adverse clinical signs. It is recommended
that pet owners and veterinarians screen cats with fevers of
unknown etiology for the presence of B. henselae. We believe
that transmission of B. henselae to humans most likely occurs
during periods of bacteremia in the cat. We have recently
demonstrated that feces from fleas feeding on bacteremic cats
are an infectious source for B. henselae (4), and consequently
flea control may reduce the potential for transmission of B.
henselae among cats and from cats to man. Clearance of B.
henselae from chronically infected cats by the use of antibiotics
is difficult (17). Antibiotic intervention may be more effective
during the initial infection, before the establishment of chronic
infection, and this approach may provide a means for decreasing the incidence of human CSD and its sequelae.
The behavioral changes seen in the LSU16-infected cats
probably are of significance. It has been known for several
years that signs of CNS disease are a serious sequela of CSD,
particularly in children (10, 13, 21). Recent reports have suggested that B. henselae may also play an important role in some
AIDS-related encephalopathies (20). Two of the cats in this
study were observed to become aggressive and excitable. The
reasons for these changes are not known; however, aggressive
and excitable behavior has been observed in human patients
with CSD (20). We were not able to isolate the organism from
the spinal fluid, although that does not preclude the possibility
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that the organism was present in the brain. Even if the organism does not cross the blood-brain barrier, damage to brain
tissue could occur via imbalances induced by the organism. For
example, induction of high systemic levels of cytokines such as
tumor necrosis factor alpha, produced in response to infection,
could lead to temporary or permanent damage to brain tissue.
A strain like LSU16, which produces these behavioral changes
in a relatively large percentage of cats (5 of 17 in the present
study), might be useful in experimental investigations into the
role of B. henselae in CNS disease.
Little is known about the interaction of B. henselae and its
host or about the virulence factors responsible for the observed
disease. B. henselae was reported to be intraerythrocytic (7,
12). It may also be a facultative intracellular organism that
avoids being killed intracellularly by macrophages via mechanisms similar to those employed by Brucella abortus, an organism to which it exhibits a high degree of evolutionary homology
(3). It has also been suggested that B. henselae is somehow
sequestered in the human host and that the resulting antigenic
stimulation and immune response account for the ensuing disease (16); thus, a strain that is more difficult to clear from the
body could have increased disease potential. The LSU16 strain
is more pathogenic in cats than the previously reported B.
henselae strains, and comparison of LSU16 with other strains
could generate useful information on the virulence factors of
this organism and its interaction with its human and feline
hosts.
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